C
China Dasheng Biotechnology Co
OTC:CDBT
China Dasheng Biotechnology Co
OTC:CDBT
Price:
0.0424
USD
37.22%
Market Cap:
$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Heritage Foods Ltd
NSE:HERITGFOOD
|
IN |
China Dasheng Biotechnology Co
Accounts Receivables
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
China Dasheng Biotechnology Co
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Dasheng Biotechnology Co
OTC:CDBT
|
Accounts Receivables
$3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Accounts Receivables
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Accounts Receivables
$1.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Accounts Receivables
$3.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Albemarle Corp
NYSE:ALB
|
Accounts Receivables
$593.5m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
No Stocks Found
China Dasheng Biotechnology Co
Glance View
China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm is not engaged in any business and has not generated any revenue.
CDBT
Intrinsic Value
Not Available
C
See Also
What is China Dasheng Biotechnology Co's Accounts Receivables?
Accounts Receivables
3.2m
USD
3.2m
USD
Based on the financial report for Jun 30, 2008, China Dasheng Biotechnology Co's Accounts Receivables amounts to 3.2m USD.
